Skip to Content

COVID-19 Info: Please help us slow the spread of coronavirus - Wear a Mask, Wash Your Hands & Wait 6 Feet Apart!
Visitor Policies and Precautions | COVID-19 Testing| Vaccine information | Commitment to Safety | Current Numbers

Clinical Trials Search Results

Showing 1-1 of 1

Sorted By:

  • SWOG S1418

    A Randomized Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer with = 1 cm Residual Invasive Cancer or Positive Lymph Nodes (ypN+) After Neoadjuvant Chemotherapy.